Report: Dementia Treatment Prevalence and Related Costs Have Increased 31% in Last Decade
November 16, 2022 | Strategic Insights for Health System
Preview
What**'**s**the**news. Treatment prevalence and related costs for Alzheimer's disease and related dementias (ADRD) have increased to $2.43 million—a 31% increase over the last decade, according to a November 2022 Milken Institute report.